Everts M - Search Results

1

Accelerating Drug Development: Antiviral Therapies for Emerging Viruses as a Model.

Everts M, Cihlar T, Bostwick JR, Whitley RJ. Everts M, et al. Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:155-169. doi: 10.1146/annurev-pharmtox-010716-104533. Epub 2016 Jul 22. Annu Rev Pharmacol Toxicol. 2017. PMID: 27483339 Review.

2

The Alabama Drug Discovery Alliance: a collaborative partnership to facilitate academic drug discovery.

Everts M, Knight WB, Harris DR, Secrist JA 3rd, Whitley RJ. Everts M, et al. Pharm Res. 2011 Jul;28(7):1454-9. doi: 10.1007/s11095-011-0432-7. Epub 2011 Mar 30. Pharm Res. 2011. PMID: 21448756 Free PMC article.

3

Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective.

Everts M, Suto MJ, Painter GR, Whitley RJ. Everts M, et al. Future Virol. 2016 Mar;11(3):187-195. doi: 10.2217/fvl-2015-0011. Epub 2016 Feb 29. Future Virol. 2016. PMID: 27325914 Free PMC article.

4

Development of vasculature targeting strategies for the treatment of cancer and chronic inflammatory diseases.

Schraa AJ, Everts M, Kok RJ, Asgeirsdóttir SA, Meijer DK, de Leij LF, Molema G. Schraa AJ, et al. Among authors: everts m. Biotechnol Annu Rev. 2002;8:133-65. doi: 10.1016/s1387-2656(02)08007-9. Biotechnol Annu Rev. 2002. PMID: 12436918 Review.

5

Combination of viral biology and nanotechnology: new applications in nanomedicine.

Saini V, Zharov VP, Brazel CS, Nikles DE, Johnson DT, Everts M. Saini V, et al. Among authors: everts m. Nanomedicine. 2006 Sep;2(3):200-6. doi: 10.1016/j.nano.2006.07.002. Nanomedicine. 2006. PMID: 17292143 Review.

6

Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells.

Oliva CR, Markert T, Ross LJ, White EL, Rasmussen L, Zhang W, Everts M, Moellering DR, Bailey SM, Suto MJ, Griguer CE. Oliva CR, et al. Among authors: everts m. J Biol Chem. 2016 Nov 11;291(46):24188-24199. doi: 10.1074/jbc.M116.749978. Epub 2016 Sep 27. J Biol Chem. 2016. PMID: 27679486 Free PMC article.

7

Thermal scalpel to target cancer.

Everts M. Everts M. Expert Rev Med Devices. 2007 Mar;4(2):131-6. doi: 10.1586/17434440.4.2.131. Expert Rev Med Devices. 2007. PMID: 17359220 Review.

8

The natural history of a novel, systemic, disseminated model of syngeneic mouse B-cell lymphoma.

Passineau MJ, Siegal GP, Everts M, Pereboev A, Jhala D, Wang M, Zhu ZB, Park SK, Curiel DT, Nelson GM. Passineau MJ, et al. Among authors: everts m. Leuk Lymphoma. 2005 Nov;46(11):1627-1638. doi: 10.1080/10428190500221454x. Leuk Lymphoma. 2005. PMID: 16334907

9

An adenoviral vector expressing human adenovirus 5 and 3 fiber proteins for targeting heterogeneous cell populations.

Murakami M, Ugai H, Wang M, Belousova N, Dent P, Fisher PB, Glasgow JN, Everts M, Curiel DT. Murakami M, et al. Among authors: everts m. Virology. 2010 Nov 25;407(2):196-205. doi: 10.1016/j.virol.2010.08.010. Epub 2010 Sep 9. Virology. 2010. PMID: 20828776 Free article.

10

Academic medical product development: an emerging alliance of technology transfer organizations and the CTSA.

Rose LM, Everts M, Heller C, Burke C, Hafer N, Steele S. Rose LM, et al. Among authors: everts m. Clin Transl Sci. 2014 Dec;7(6):456-64. doi: 10.1111/cts.12175. Epub 2014 Jun 19. Clin Transl Sci. 2014. PMID: 24945893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters